CoQ10 vs Vesugen
A side-by-side research comparison of CoQ10 and Vesugen across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | CoQ10 | Vesugen |
|---|---|---|
| Full name | Coenzyme Q10 (Ubiquinol) | Vesugen (Lys-Glu-Asp Vascular Bioregulator) |
| Category | Cardiovascular | Cardiovascular |
| Status | Dietary supplement | Research compound (peptide bioregulator) |
| Mechanism | Shuttles electrons in the mitochondrial respiratory chain (Complex I→III). As ubiquinol, neutralizes lipid peroxyl radicals protecting cell membranes and LDL from oxidation. Restores mitochondrial membrane potential. | As a signal peptide (Lys-Glu-Asp), it is proposed to enter cells and regulate gene expression in vascular tissue, supporting endothelial function, vascular tone, and normal vessel-wall maintenance. |
| Molecular weight | 863.34 Da | ~390 Da |
| Half-life | ~33 hours (ubiquinol) | Short (peptide) |
| Bioavailability | ~6-9% (standard); ~300% improved with ubiquinol/lipid formulations | Oral (encapsulated) or subcutaneous |
| Typical dose | 100-300 mg ubiquinol | ~1-2 capsules/day or short injectable courses |
| Frequency | Daily with fat-containing meal | Once daily |
| Route | Oral softgel | Oral capsule or subcutaneous |
CoQ10 reported benefits
- Mitochondrial energy production
- Cardiac function support
- Antioxidant protection
- Statin side effect mitigation
- Exercise performance
- Fertility support (egg/sperm quality)
Vesugen reported benefits
- Vascular/endothelial support
- Proposed vascular tissue regulation
- Short course-based protocol
- Part of bioregulator longevity systems
Related comparisons
Research and educational reference only. Not medical advice.